%0 Journal Article
%A G`opirjonova D.D, G`opirjonova D.D
%A Alyavi A.L, Alyavi A.L
%D 2024
%F arxiv:100046
%J "Conference on Universal Science Research 2023"
%K ischemic heart disease, endothelin-1, inflammation, biomarkers, neurohormanal activation.
%N 5
%P 96-97
%T ENDOTHELIN-1 IN PATIENTS WITH ISCHEMIC HEART DISEASE
%U https://arxiv.universalpublishings.com/id/eprint/100046/
%V 2
%X Ishemia or ischemic heart disease is the leading cause of disability and premature deaths worldwide. IHD is a condition in which the heartis starved of oxygen due to a redused blood spply. Deapite a large pool of interesting candidate biomarkers, endothelin-1 (ET-1) appears to be involvedin multiple aspecis of IHD pathogenesis that include neurohormonal activation, cardiac remodeling, endothelial dysfunction, inflammation, atherosclerosis and alteration of the renal function. ET-1 production and release can be upregulated by inflammatory factors, such as IFN-γ and IL-1β, during disease